Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma.

Abramson JS, Stuver R, Herrera A, Patterson E, Wen YP, Moskowitz A

DOI: 10.1016/j.critrevonc.2024.104499
Published: 2024 Dec
Container: Critical reviews in oncology/hematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.critrevonc.2024.104499,
  title = {Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma.},
  author = {Abramson JS and Stuver R and Herrera A and Patterson E and Wen YP and Moskowitz A},
  year = {2024},
  journal = {Critical reviews in oncology/hematology},
  doi = {10.1016/j.critrevonc.2024.104499},
  url = {https://doi.org/10.1016/j.critrevonc.2024.104499}
}

RIS

TY  - JOUR
TI  - Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma.
AU  - Abramson JS
AU  - Stuver R
AU  - Herrera A
AU  - Patterson E
AU  - Wen YP
AU  - Moskowitz A
PY  - 2024
JO  - Critical reviews in oncology/hematology
DO  - 10.1016/j.critrevonc.2024.104499
UR  - https://doi.org/10.1016/j.critrevonc.2024.104499
ER  -

APA

JS, A., R, S., A, H., E, P., YP, W., & A, M. (2024). Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2024.104499

Source records

pubmed · retrieved 2026-09-26T14:55:44.977Z